# Guy Jérusalem

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/guy-jerusalem/

## Facts

| Field | Value |
| --- | --- |
| Citations | 22,859 |
| Field | Advanced Breast Cancer Therapies |
| h-index | 68 |
| i10-index | 207 |
| Last Known Institution | University of Liège |
| OpenAlex ID | https://openalex.org/A5071675004 |
| ORCID iD | https://orcid.org/0000-0002-8845-0043 |
| Works | 700 |

## Researcher papers

- [Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial](https://scholariq.org/papers/pembrolizumab-plus-trastuzumab-in-trastuzumab-resistant-advanced-her2-positive/)

## Researcher topics

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer survivorship and care](https://scholariq.org/topics/cancer-survivorship-and-care/)

## Researcher university

- [University of Liège](https://scholariq.org/institutions/university-of-liege/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.